Roland H. Good

Learn More
AUTHORS’ NOTE: This research was funded by the U.S. Department of Education, Office of Special Education Programs, as part of the Early Childhood Research Institute on Measuring Growth and Development (Grant H024S600010). The authors thank the co-investigators of this project (Drs. Ruth Kaminski, Roland Good, Karen Rush, Judy Carta, Charles Greenwood, Gayle(More)
The effectiveness of a comprehensive intervention with preschool children aimed at reducing the risk of later substance abuse was examined. The intervention targeted risk factors during the preschool years linked to later substance use in adolescence and adulthood. Head Start classrooms were randomly assigned to either the intervention or the control group.(More)
Hypothesis validity refers to the extent to which research results reflect theoretically derived predictions about the relations between or among constructs. The role of hypotheses in theory testing is discussed. Four threats to hypothesis validity are presented: (a) inconsequential research hypotheses, (b) ambiguous research hypotheses, (c) noncongruence(More)
The major platform of the Council of Australian Governments (COAG) water reform program is the equitable and sustainable sharing of surface and groundwater resources between the environment and consumptive water users. In the regulated section of the Murrumbidgee River below Burrinjuck Dam, approximately 2,800 GL of the available surface water (4,300 GL) is(More)
ABSTRACT Studies of human information processing have identified two basic ways people process information. Sequential learning solves problems by arranging small amounts of information in consecutive and linear order. Simultaneous processors solve problems by integrating and synthesizing parallel pieces of information at the same time. This study(More)
PURPOSE To determine the effects of sargramostim (recombinant human granulocyte-macrophage colony-stimulating factor [rhu GM-CSF]) on the incidence, duration, and complications of myelosuppression after moderate-dose fluorouracil, doxorubicin, cyclophosphamide (FAC) adjuvant chemotherapy in patients with node-positive breast cancer. PATIENTS AND METHODS(More)